scholarly journals COVID-19: An Insight Into the Pandemic of a New Emerging Coronavirus

2020 ◽  
Vol 4 (1) ◽  
pp. 7-12
Author(s):  
Olusola A. Akanbi ◽  
Oluyinka O. Opaleye ◽  
Adekunle O. Olowe ◽  
Olusola Ojurongbe

Since Decem ber 2019, a novel Cor onavir us nam ed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been implicated in an outbreak of SARSlike illness, which began in a wild animal market of Wuhan in Hubei province of China and the World Health Organization (WHO) was alerted on the 31st December 2019 of this public health threat. On the 11th March 2020, the WHO announced that this disease termed COVID-19 has become pandemic, the first for any coronavirus. Coronaviruses are a large family of viruses that cause illness such as the common cold to more severe diseases such as SARS. To date, the virus has spread to over 100 countries, including 40 countries in Africa, including Nigeria. As at the time of this publication over 300,000 cases has been reported world-wide with over 14,000 deaths mostly from China and Italy. The Nigerian Centre for Disease Control (NCDC) has since put in place measures to contain and prevent the further spread of the virus. This review highlights the current situation and knowledge of the newly emerged SARS-CoV-2 and its epidemiological trends.

Author(s):  
Ghotekar D S ◽  
Vishal N Kushare ◽  
Sagar V Ghotekar

Coronaviruses are a family of viruses that cause illness such as respiratory diseases or gastrointestinal diseases. Respiratory diseases can range from the common cold to more severe diseases. A novel coronavirus outbreak was first documented in Wuhan, Hubei Province, China in December 2019. The World Health Organization (WHO) has declared the coronavirus disease 2019 (COVID-19) a pandemic. A global coordinated effort is needed to stop the further spread of the virus. A novel coronavirus (nCoV) is a new strain that has not been identified in humans previously. Once scientists determine exactly what coronavirus it is, they give it a name (as in the case of COVID-19, the virus causing it is SARS-CoV-2).


2020 ◽  
Vol 11 (SPL1) ◽  
pp. 907-912
Author(s):  
Deepika Masurkar ◽  
Priyanka Jaiswal

Recently at the end of 2019, a new disease was found in Wuhan, China. This disease was diagnosed to be caused by a new type of coronavirus and affected almost the whole world. Chinese researchers named this novel virus as 2019-nCov or Wuhan-coronavirus. However, to avoid misunderstanding the World Health Organization noises it as COVID-19 virus when interacting with the media COVID-19 is new globally as well as in India. This has disturbed peoples mind. There are various rumours about the coronavirus in Indian society which causes panic in peoples mind. It is the need of society to know myths and facts about coronavirus to reduce the panic and take the proper precautionary actions for our safety against the coronavirus. Thus this article aims to bust myths and present the facts to the common people. We need to verify myths spreading through social media and keep our self-ready with facts so that we can protect our self in a better way. People must prevent COVID 19 at a personal level. Appropriate action in individual communities and countries can benefit the entire world.


Coronaviruses ◽  
2020 ◽  
Vol 1 (1) ◽  
pp. 49-56
Author(s):  
Gaurav M. Doshi ◽  
Hemen S. Ved ◽  
Ami P. Thakkar

The World Health Organization (WHO) has recently announced the spread of novel coronavirus (nCoV) globally and has declared it a pandemic. The probable source of transmission of the virus, which is from animal to human and human to human contact, has been established. As per the statistics reported by the WHO on 11th April 2020, data has shown that more than sixteen lakh confirmed cases have been identified globally. The reported cases related to nCoV in India have been rising substantially. The review article discusses the characteristics of nCoV in detail with the probability of potentially effective old drugs that may inhibit the virus. The research may further emphasize and draw the attention of the world towards the development of an effective vaccine as well as alternative therapies. Moreover, the article will help to bridge the gap between the new researchers since it’s the current thrust area of research.


2020 ◽  
Author(s):  
Mujib Ullah

UNSTRUCTURED Coronaviruses belong to a large family of viruses. Coronavirus also called COVID-19 is a new disease that has not been previously identified in humans. The World Health Organization has announced that COVID-19 is a pandemic. Currently there is no specific vaccine or treatment for COVID-19. Current treatment for COVID-19 is only supportive (treating the symptoms). There are no antiviral or vaccine options at this time. Therefore, it is time to bring collective efforts to treat or prevent a rapidly evolving pandemic of COVID-19.


2020 ◽  
Vol 31 (11) ◽  
pp. 467-471
Author(s):  
Anne Cartwright

Errors in the prescribing, dispensing and administration of insulin can cause serious harm. Anne Cartwright raises awareness of the risks In 2010 National Patient Safety Alerts produced a rapid response report ‘Safer Use of Insulin’ in response to an increasing number of medication incidents leading to severe harm or death as a result of errors with insulin therapy. In 2017 the World Health Organization launched a global initiative to reduce avoidable medication error by 50% over 5 years. This article aims to raise awareness of the risks of insulin therapy, the common mistakes that can be made in the prescribing, dispensing and administration of insulin, and to inform health professionals who are involved in caring for people on insulin therapy how to reduce the risk of potential harm.


Author(s):  
SWAGATIKA PRIYADARSINI ◽  
ROHIT SINGH ◽  
ARUN SOMAGOND ◽  
PUJA MECH

Coronavirus disease is the current cause of global concern. The massive outbreak of COVID-19 has led the World Health Organization (WHO) to declare this as a pandemic situation. The Severe Acute Respiratory Syndrome Coronavirus-2 (SARSCoV-2) is responsible for COVID-19 leading to acute respiratory distress and substantial mortality in humans. However, the first laboratory confirmation of SARS-CoV-2 in a pet dog in Hong Kong has shown the possibility of human-to-animal transmission (zooanthroponotic) of the virus. Thereafter, many animals including cat, tiger, lion and mink have also been reported to acquire the virus in several countries. In this situation the role of veterinarian assumes important in treating the animals, helping in food security, disease diagnosis, surveillance and boosting the economy of livestock stakeholders at the grassroot level. In the absence of any selective vaccine or drug against SARS-CoV-2, the world is anticipated to triumph over this pandemic with collaborative, multisectoral, and transdisciplinary approach linking human, animal and environmental health. This article gives an insight into the confirmed SARS-CoV-2 outbreaks in animals, including the factors behind the shuffling of the virus among variety of species and also emphasizes on the role of veterinarian in managing and safeguarding public health so as to pave the way for adopting one health approach in order to conserve biodiversity.


2021 ◽  
Vol 22 (21) ◽  
pp. 12024
Author(s):  
Chiara Stassi ◽  
Cristina Mondello ◽  
Gennaro Baldino ◽  
Luigi Cardia ◽  
Alessio Asmundo ◽  
...  

On 11 March 2020, the World Health Organization (WHO) declared a pandemic due to the spread of COVID-19 from Wuhan, China, causing high mortality rates all over the world. The related disease, which mainly affects the lungs, is responsible for the onset of Diffuse Alveolar Damage (DAD) and a hypercoagulability state, frequently leading to Severe Acute Respiratory Syndrome (SARS) and multiorgan failure, particularly in old and severe-critically ill patients. In order to find effective therapeutic strategies, many efforts have been made aiming to shed light on the pathophysiology of COVID-19 disease. Moreover, following the late advent of vaccination campaigns, the need for the comprehension of the pathophysiology of the fatal, although rare, thrombotic adverse events has become mandatory as well. The achievement of such purposes needs a multidisciplinary approach, depending on a correct interpretation of clinical, biochemical, biomolecular, and forensic findings. In this scenario, autopsies have helped in defining, on both gross and histologic examinations, the main changes to which the affected organs undergo and the role in assessing whether a patient is dead “from” or “with” COVID-19, not to mention whether the existence of a causal link exists between vaccination and thrombotic adverse events. In the present work, we explored the role of postmortem immunohistochemistry, and the increasingly used ancillary technique, in helping to understand the mechanism underlying the pathophysiology of both COVID-19 disease and COVID-19 vaccine-related adverse and rare effects.


2017 ◽  
Vol 10 (4) ◽  
pp. 224-227
Author(s):  
Rabia Aftab

The Zika virus (ZIKV), first discovered in 1947, has emerged as a global public health threat over the last decade, with an accelerated geographic spread of the virus occurring in the last 5 years. The World Health Organization (WHO) predicts that millions of cases of ZIKV are likely to occur in the Americas between 2016 and 2017. These projections, in conjunction with an increase in newborn microcephaly cases that are suspected to be ZIKV-associated, prompted the WHO to declare a public health emergency of international concern in February 2016. With the current media attention, it is likely that GPs will be consulted on th topic, particularly by pregnant women.


2020 ◽  
Author(s):  
ARNAB SAHA ◽  
Komal Gupta ◽  
Manti Patil ◽  
Urvashi

COVID-19 has struck fear into populaces all through the world and shocked the worldwide restorative community, with the World Health Organization (WHO) pronouncing it a widespread as it were approximately three months after the flare-up of the infection. A new different virus (primarily called ‘Novel Coronavirus 2019-nCoV’) causing severe acute respiratory syndrome (coronavirus disease COVID-19) emerged in Wuhan, Hubei Province, China in December 2019 and rapidly spread to other parts of China and other countries around the world. The outbreak of the novel coronavirus disease (COVID-19) has caused more than 850,000 people infected and approx. 40000 of deaths in more than 190 countries up to March 2020, extremely affecting economic and social development. Presently, the number of infections and deaths is still increasing rapidly. COVID-19 seriously threatens human health, production, life, social functioning and international relations. In the fight against COVID-19, Geographic Information Systems (GIS) and big data technologies have played an important role in many aspects. This paper describes the usage of practical GIS and mapping dashboards and applications for monitoring the coronavirus epidemic and related activities as they spread around the world. At the facts level, in the generation of massive data, information no longer come on the whole from the authorities but are gathered from greater diverse enterprises. As of now and for a long time in the future, the improvement of GIS should be fortified to create a data-driven framework for fast information securing, which implies that GIS ought to be utilized to fortify the social operation parameterization of models and methods, particularly when giving back for social administration.


2008 ◽  
Vol 14 (2) ◽  
pp. 7
Author(s):  
Russell Renhard ◽  
Steve Einfeld

This is the first occasion the Journal has published a special issue on safety and quality in primary health, although of course individual articles on the subject have appeared in its pages. The timing of the issue reflects significant world-wide interest evidenced in a growth of specialist safety and quality-related journals, conferences, World Health Organization programs, as well as policy initiatives by governments all over the world.


Sign in / Sign up

Export Citation Format

Share Document